|
|
Volumn 8, Issue 6, 1997, Pages 513-514
|
|
The increased armament in the battle against non-small-cell lung cancer
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ALKALOID;
ANTINEOPLASTIC ANTIMETABOLITE;
CARBOPLATIN;
CISPLATIN;
DOCETAXEL;
ETOPOSIDE;
GEMCITABINE;
IRINOTECAN;
NAVELBINE;
PACLITAXEL;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
EDITORIAL;
HUMAN;
LUNG CANCER;
LUNG NON SMALL CELL CANCER;
MAJOR CLINICAL STUDY;
META ANALYSIS;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROGNOSIS;
QUALITY OF LIFE;
TREATMENT OUTCOME;
CARCINOMA, NON-SMALL-CELL LUNG;
HUMANS;
LUNG NEOPLASMS;
RANDOMIZED CONTROLLED TRIALS;
|
|
EID: 0030851248
PISSN: 09237534
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1008263210409 Document Type: Editorial |
|
Times cited : (2)
|
|
References (8)
|
